OSF Cancer Institute is one of the chosen few participants in an exciting new cancer treatment trial program. The founder of ...

On November 8, the Department of Labor (DOL) issued an opinion letter addressing an interesting question under the Family and ...

Satellos Bioscience has dosed the first subject with Duchenne muscular dystrophy (DMD) in a Phase Ib trial of its oral small ...

The trial explores how Apple smartwatches can help tailor daily blood thinner use for patients with atrial fibrillation.

For patients with "good-risk" ductal carcinoma in situ (DCIS) who underwent breast-conserving surgery and did not receive ...

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...

RevBio Receives Both FDA Approval to Expand its Clinical Trial and CMS Reimbursement for its Regenerative Bone Adhesive for ...

Discover key challenges in clinical trial design and learn how the right software can significantly boost the likelihood of ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, whose ...

After a lucrative IPO in September, Richmond-based BioAge is seeing its biotech fortunes shift with its stock falling over 70 ...

A new Houston-developed AI model is being used in a clinical trial for the first time, and researchers are watching for more.

WHISTLE-PF will test the efficacy of various daily oral doses of ENV-101 against a placebo in adults with idiopathic ...